Development and validation of a paediatric oral formulation of clonidine hydrochloride

Int J Pharm. 2012 Aug 20;433(1-2):119-20. doi: 10.1016/j.ijpharm.2012.04.055. Epub 2012 May 9.

Abstract

Many drugs are unavailable in suitable paediatric dosage forms. We describe the development and validation of a stable paediatric oral formulation of clonidine hydrochloride 50 μg/ml, allowing individualised paediatric dosing and easy administration. Stability of the extemporaneously compounded formulation of clonidine hydrochloride was assessed using a validated HPLC method. Clonidine hydrochloride was stable in the buffered aqueous solution at room temperature for up to 9 months. The described formulation is chemically stable for at least 9 months when stored in brown 100 ml PET bottles at room temperature, enabling adequate oral treatment in paediatric patients.

Publication types

  • Validation Study

MeSH terms

  • Administration, Oral
  • Adrenergic alpha-2 Receptor Agonists / administration & dosage*
  • Adrenergic alpha-2 Receptor Agonists / chemistry
  • Child
  • Chromatography, High Pressure Liquid / methods*
  • Clonidine / administration & dosage*
  • Clonidine / chemistry
  • Drug Compounding / methods*
  • Drug Stability
  • Drug Storage
  • Humans
  • Pharmaceutical Solutions
  • Temperature

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Pharmaceutical Solutions
  • Clonidine